Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GMDA

Gamida Cell (GMDA) Stock Price, News & Analysis

Gamida Cell logo

About Gamida Cell Stock (NASDAQ:GMDA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.01
$0.40
52-Week Range
N/A
Volume
23.04 million shs
Average Volume
9.20 million shs
Market Capitalization
$5.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GMDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter.

GMDA Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Q4 2023 Gamida Cell Ltd Earnings Call
Why Gamida Cell Shares Are Falling Today
See More Headlines

GMDA Stock Analysis - Frequently Asked Questions

Gamida Cell Ltd. (NASDAQ:GMDA) announced its quarterly earnings data on Monday, August, 14th. The company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.13.

Gamida Cell (GMDA) raised $50 million in an IPO on Friday, October 26th 2018. The company issued 3,600,000 shares at $13.00-$15.00 per share. BMO Capital Markets and RBC Capital Markets acted as the underwriters for the IPO and Needham & Company Oppenheimer & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gamida Cell investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), Bank of America (BAC), JPMorgan Chase & Co. (JPM), Zomedica (ZOM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
8/14/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GMDA
CIK
1600847
Fax
N/A
Employees
143
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.63)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63 million
Net Margins
N/A
Pretax Margin
-3,531.17%
Return on Equity
N/A
Return on Assets
-57.59%

Debt

Debt-to-Equity Ratio
213.14
Current Ratio
2.16
Quick Ratio
2.09

Sales & Book Value

Annual Sales
$1.78 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
154,051,000
Free Float
143,699,000
Market Cap
$5.04 million
Optionable
Optionable
Beta
0.93
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:GMDA) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners